Background: Osteopontin (OPN) is reportedly involved in bone desorption, formation and ectopic calcification. We sought to investigate the role of OPN gene polymorphism in the susceptibility to Cervical spondylotic myelopathy (CSM) and in predicting the outcome anterior cervical corpectomy and fusion (ACF). Methods: A total of 187 patients diagnosed with CSM and 233 sex and age matched healthy controls were enrolled in this study. All CSM patients received ACF and were followed up for 24 months. The polymorphisms of OPN gene at 3 loci, namely, −156 G>GG, −443 C>T and -66T>G were determined. Results: The -66T>G genotype was significantly different between CSM patients and controls. Compared to the -66TT carriers, the -66GG genotype carriers had a higher risk for developing CSM (adjusted Odd Ratio=2.58, adjusted P=0.001). In contrast, the genotype distributions of the -156G/GG and -443C/T loci were not significantly different between the CSM and control groups. OPN gene polymorphism did not determine the pre-operative severity of CSM patients, but the -66T>G genotype was significantly associated with the clinical outcome of CSM after ACF treatment. The -66T>G did not affect the serum OPN level, but affect the local expressions of OPN and a serious of key inflammatory factors in the intervertebral disc samples. Conclusion: Our study shows the OPN -66T>G genetic polymorphism contributes to patients' susceptibility to CSM and could be indicative of the outcome of ACF surgery.
Introduction
Cervical spondylotic myelopathy (CSM) is a well-known clinical syndrome in the elderly. CSM is described by the symptoms and signs caused by stimulation and compression of the spinal cord due to cervical intervertebral disk degeneration diseases and secondary changes. Epidemiological studies show that environmental factors, including age, gender, smoking and obesity were responsible for the incidence of chronic spine disorders [1, 2] . Additionally, the genetic factor is also involved in the degeneration process of spine disorders, including CSM [3, 4] .
Osteopontin (OPN) is an acidic, noncollagenous matrix protein produced by the bone and kidneys. OPN is associated with many pathologic conditions, including cancer [5] , autoimmune disease [6] , and cardiovascular disease [7, 8] . Moreover, OPN is reportedly involved in bone desorption and formation [9] . Recent study shows that high serum OPN level is associated with a low bone mineral density in postmenopausal women [10] . OPN also well known as a molecule that consistently colocalizes with ectopic calcification and is over-expressed in the hyperostotic spinal lesions [11] .
The expression of OPN is significantly influenced by its genetic polymorphisms of the promoter [12] . Several polymorphisms in the human OPN encoding gene have been identified in different populations, of which the −156 G>GG, −443 C>T and -66T>G polymorphisms are mostly studied. These OPN genetic polymorphisms have been reported in association with inflammatory disease e.g. systemic lupus erythematosus [13] , chronic hepatitis C [14] , lupus nephritis [15] and large artery atherosclerosis [16] . However the role of OPN expression and its gene polymorphisms with CSM remains unknown.
Materials and Methods

Enrolment
A total of 187 patients diagnosed with CSM were enrolled in the study from September 2007 to June 2011. The diagnoses were established on the basis of findings from the history, physical examination and confirmed by magnetic resonance imaging [17] as previously described. The control samples consisted of 233 sex and age matched healthy Chinese individuals with negative MRI findings. Exclusion criteria included congenital cervical anomalies, trauma, prior cervical surgery, rheumatoid arthritis, infections, tumors, ankylosing spondylitis, ossification of the posterior longitudinal ligament, diffuse idiopathic skeletal hyperostosis, and any other inflammatory disease involving the cervical spine. The clinical characteristics including sex, age, weight, height, body mass index (BMI), daily desk work time, smoking status and family history of intervertebral degenerative disc disease were collected. The study protocol was approved by the Ethics Committees Ethical Committee at Department of orthopedics, The Affiliated Hospital of Xuzhou Medical College, Written informed consent was obtained from all patients before participation in the study.
Follow-Up and Outcome Assessment
All patients received anterior cervical corpectomy and fusion (ACF) and were followed up. Based on the clinical symptoms and signs, the severity of neurological deficits of all these preoperative patients was scored one day before and 24 months after ACF according to the modified Japanese Orthopedic Association (modified JOA) score for CSM. [18] The patients were dichotomized into two groups according to the mJOA scores: improvement group (at least 50% or higher improvement in mJOA score at the last follow-up compared with the pre-operative score) and a non-improvement group (the improvement of mJOA score at last follow-up was less than 50%, equal, or less than the pre-operative mJOA score) [19] .
Measurement of serum OPN
Serum OPN levels were measured using the Quantikine Human OPN immunoassay kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. Intraassay coefficient of variation (CV) was 4% and inter-assay CV was 6.6%.
Western blot assay
The intervertebral disc samples were collected during surgery from CSM patients underwent the anterior cervical corpectomy and fusion. Samples were homogenized and lysed. Extracts were resolved on SDS-polyacrylamide gels followed by transferring to nitrocellulose membranes (BioRad). Proteins were detected by using antibodies against OPN (1:1000, Abcam, USA), interleukin-12 (IL12, Abcam, USA), tumor necrosis factor alpha (TNF-α, Abcam, USA) and interferon-γ (IFN-γ) and GAPDH (1:5000, Santa Cruz). The intensity of the specific bands was calculated using densitometry analysis (Image Station 4000R Pro; Eastman Kodak, Rochester, NY). The quantitative analyses were performed by using TINA software. The OPN expression levels were quantified by the ratio between the individual density of OPN band minus background and GAPDH minus background.
OPN gene polymorphisms DNA was extracted from peripheral whole blood using a Qiagen DNA Isolation Kit (Qiagen, Valencia, CA, USA). Three single nucleotide polymorphisms in the promoter region of OPN gene, including -66T>G (rs28357094), -156G>/GG (rs17524488), and -443C>T (rs11730582), were determined using the TaqMan 5′ allelic discrimination assay. It was performed using a commercially available kit Assays-on-DemandTM SNP genotyping products (Applied Biosystems, Foster City, CA). SNP amplification assays were used according to the manufacturer's instructions. In short, 10 ng of sample DNA in 25 µL of reaction solution containing 12.5 µL of the 2× TaqMan® Universal PCR Mix (Applied Biosystems), and 1.25 µl of pre-developed assay reagent from the SNP genotyping product containing two primers and two MCB-Taqman probes. Reaction condition was consisted of pre incubation at 50 °C for 2 min, at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Amplifications were performed in an ABI Prism® 7500 Sequence Detection System (Applied Biosystems).
Statistical Analysis
Data on quantitative characteristics are expressed as means ± SD. Data on qualitative characteristics are expressed as percent values or absolute numbers, as indicated. Differences in demographic characteristics and vascular risk factors between patients and controls were compared by using Student's t test or ANOVA for continuous variables and the χ2 test for all categorical variables. To estimate the deviation of frequency of gene alleles in the tested population, we performed the Hardy-Weinberg equilibrium using χ2 tests. Genotypes and allele frequencies were compared by the χ2 analysis or Fisher's exact test. Multivariate logistic regression analysis was used to determine the influence of OPN polymorphisms on CSM, controlling potential confounding conventional risk factors. A forward stepwise (Likelihood Ratio) procedure was used for the multivariable analysis. Data were analyzed using the SPSS 16.0 package (Statistical Package for the Social Sciences, version 16.0, SPSS Inc, Chicago, IL, USA).The results were considered statistically significant at P < 0.01 using a 2-tailed test. Table 1 shows the clinical characteristics of CSM patients and controls. There was no significant difference in age, sex and BMI between two groups; however, CSM patients had significantly higher rates of smokers and family history and longer daily desk work working time than controls (all P<0.05). Table 2 describes the genotype and allele distributions of OPN gene polymorphisms in the CSM and control groups. The genotype frequencies for all polymorphisms did not differ significantly from those expected under Hardy-Weinberg equilibrium (all P>0.05). For the -66T>G polymorphism, CSM patients had a higher prevalence of GG genotype than the controls (27.42% vs.16.31%, P<0.001). We performed the univariate and multivariate logistic regression analysis with the adjustment of age, sex, BMI, smoking status, family history status and daily desk work time. Compared with the -66TT carriers, our data showed that the -66GG genotype carriers were significantly related to a higher CSM risk (adjust OR=2.58, 95%CI: 1.44-4.59, adjusted P=0.001). In contrast, the genotype distribution of -156G/GG and -443C/T were not significantly different between the CSM and control groups. 
Results
Cellular Physiology and Biochemistry
We next compared the OPN expression in intervertebral disc samples from CSM patients underwent CAF treatment. Figure 3 shows the typical bands of samples from CSM patients. Our results showed that the -66T>G gene polymorphisms significantly affected the local OPN expression in intervertebral disc. The OPN expression was apparently lower in the -66TT OPN -66T>G genetic polymorphism contributes to the susceptibility to CSM and could be indicative of the outcome of ACF surgery.
OPN is one of the most abundant non-collagenous proteins in bone [21] , originally isolated from bone, and is also found in the kidney, vascular and immune systems [22] . Hou et al reported that Serum OPN is related to LVH incidence in essential hypertension subjects by stimulating cardiomyocyte hypertrophy in vitro, but not OPN gene polymorphisms at -66T/G, -156G/GG, and and -443C/T [8] . Serum OPN levels confer the susceptibility and prognosis of ischemic stroke in Chinese patients [23] . In bones, OPN is produced by osteoblasts and osteoclasts, and involved in bone resorption and formation [24] . It has been suggested that OPN may facilitate the adhesion (or detachment) of the osteoclast to the bone surface and act as a signaling molecule or a scaffold in normal bone metabolism and turnover [22, 25, 26] . In human, high OPN levels have been indicated as a risk factor for low bone mineral density in postmenopausal women and used as a biomarker for early osteoporosis diagnosis [27] . Studies have shown that a high level of osteopontin mRNA and protein expression occurs in both intramembranous and endochondral ossification, as well as remodeling bone, including the human osteophyte [28] . The latter has been shown, at least partially, contributing to the pathology of CSM.
In this study, we intended to understand the roles of OPN polymorphisms in CSM, which have previously not been determined. We selected the −156 G>GG, −443 T>C and -66 G>T polymorphisms in the promoter region of the OPN gene that have been mostly studied in other disease conditions. Among the studied polymorphisms, the -443 T>C and -156 G>GG polymorphisms have been shown in linkage disequilibrium. The -443 T>C polymorphism is at the binding site of MYT1 zinc finger factor and has been formerly correlated to the development of neurogenesis and the status of hepatitis activity [29] . The -156 G>GG polymorphism may interfere with the binding affinity of transcription factor, RUNX2, and has been associated with the increased risk of systemic lupus erythematous [30] and oral squamous cell carcinoma [12, 31, 32] . As for the -66 G>T polymorphism, its implications in disease development have yet been established. Our study indicates that the higher frequency of the -66 GG genotypic carriers among the CSM patients, compared with the paired control. Although the underlying mechanisms are unclear, studies have shown that the expression of OPN is significantly affected by transcription factors and the genetic polymorphisms in the promoter [12] . Thereby, we compared the levels of OPN expression in the intervertebral disc and ligament samples from CSM patients among the -66TT, -66GG and -66GT carriers. Indeed, we found that the OPN expression was greatly lower in the -66GG carriers compared with both the -66GG and -66GT carriers. In contrast, the -443 C>T and -156G>GG were not associated with the levels of OPN protein expression. Our results suggest that the -66T>G gene polymorphisms may affect the protein expression of OPN in intervertebral disc, therefore modifying the carriers' susceptibility to CSM.
Interestingly, we did not see the OPN gene polymorphism affect the serum OPN level, however, we noted the -66T>G polymorphism influenced the local OPN expression in the intervertebral disc. Also, we found that the -66GG carriers had significantly higher expressions of key cytokines, i.e. NF-kB, IL-12, TNF-α, and IFN-γ in the intervertebral disc. OPN is an important cytokine that presents at the site of wound and serves as a chemotactic factor to recruit inflammatory cells to the injury site [21] . OPN functions as a pro-inflammatory cytokine and regulates the immune responses by increasing the Th1 cytokines expression, such as IL-12 from macrophages, TNF-α from dendritic cells, and IFN-γ and IL-17 by T cells [22] . OPN selectively regulates intercellular adhesion molecule-1(ICAM-1) expression in breast cancer cells via NF-kappa B pathway [33] . The gene polymorphism of OPN was also associated with several inflammatory conditions, such as osteoarthritis [34] and lupus [35] . OPN is expressed in bone matrix. In Chinese patients, the polymorphisms of the OPN -443C>T and the -66T>G were significantly associated with the osteoarthritis risk and its the radiographic severity by reducing the lower thrombin-cleaved OPN levels in synovial fluid. The OPN rs28357094 (-66T/G in our study) allele was associated with increased serum IFN-α activity in Juvenile Dermatomyositis patients. The OPN allele was most strongly enriched in female carriers of TNF-alpha-308A as compared with male carriers of TNF-alpha-308A [36] . Consistent with the above mentioned studies, in the current study, we found that the -66T>G genotype significantly dramatically affected the expressions of a serious of key inflammatory factors, including NF-kB, IL-12, TNF-α and IFN-γ.Therefore, the association between OPN genetic polymorphism and development of CSM may be mediated through the increment of cytokine production and the inflammatory process, which might be resulted from injury occurred at the cervical vertebrae.
Our study did not support the correlation between the OPN polymorphism and the severity of CSM using the JOA score. However, the logistic regression analysis indicated that the TT carriers of -66T>G polymorphisms is associated with a higher chance of gaining improvement from ACF surgery based on the JOA scores. The OPN genetic polymorphism can be used as a disease severity and prognosis marker, e.g., the polymorphism in promoter region of OPN gene reflects the hepatitis activity in chronic hepatitis C patients [14] . In addition, the OPN gene polymorphism predicts the efficacy of IFN-based therapies in patients with chronic hepatitis C [37] . Our study, for the first time, provide evidence that the OPN -66T>G genotype is correlated to the surgical treatment outcome in CSM patients. Based on the correlation of the -66T>G genotype and the inflamationatory factor expression, we assume that the different local inflammation level at the cervical spine may be a reason for their different post-operative outcome. Studying the polymorphism of OPN, therefore, may potentially provide an alternative prognostic indicator to evaluate the ACF surgical candidates.
In conclusion, our study suggests that -66 G>T polymorphism of the OPN gene may play a pivotal role in the development of CSM via increased production of cytokines and inflammatory activation. It may also be indicative of whether ACF surgical candidates would gain improvement after the surgical treatment. Both a larger scale of investigation on CSM patients and multiple animal studies in vivo or in vitro are necessary to confirm our findings.
